1. Compression Vest Treatment for Symptomatic Breast Edema in Women Treated for Breast Cancer: A Pilot Study.
- Author
-
Gregorowitsch ML, Van den Bongard DHJG, Batenburg MCT, Traa-van de Grootevheen MJC, Fuhler N, van Het Westeinde T, van der Pol CC, Young-Afat DA, and Verkooijen HM
- Subjects
- Breast Cancer Lymphedema etiology, Breast Cancer Lymphedema pathology, Breast Cancer Lymphedema psychology, Breast Neoplasms complications, Breast Neoplasms pathology, Breast Neoplasms surgery, Edema etiology, Edema pathology, Edema psychology, Female, Humans, Middle Aged, Pain etiology, Pain pathology, Pain psychology, Pain Measurement, Pilot Projects, Pressure, Severity of Illness Index, Breast Cancer Lymphedema therapy, Breast Neoplasms psychology, Compression Bandages, Edema therapy, Pain prevention & control, Quality of Life psychology
- Abstract
Background: Lymphedema of the breast/chest wall after breast cancer treatment is often associated with pain and reduced quality of life. We conducted a pilot study to evaluate whether the use of a compression vest reduced symptoms of breast/chest wall edema in breast cancer patients. Methods and Results: This single-center study included patients ( n = 25) with symptomatic breast/chest wall edema with a pain score of ≥3 on the Numerical Rating Scales (range 1-10). The patients were instructed to wear a compression vest (Lymphatrex, Class II) for 6 months. Wilcoxon signed-rank tests were used to compare differences in patient-reported pain intensity/severity. Analyses included all patients with available data. In total, 17 (68%) continued to wear their vests for 6 months, whereas the other 8 withdrew prematurely. At baseline, median pain severity (4.9, interquartile range [IQR] 3.6-6.0) and pain interference (4.3, IQR 2.1-5.9) scores were significantly higher compared with pain scores after wearing the compression vest for 6 months (1.8 IQR 1.0-4.8 and 1.4 IQR 0.9-4.4, resp.). Patient-reported breast/chest wall swelling decreased from 92% ( n = 22) at baseline to 71% ( n = 12) at 6 months. The prevalence of moderate/severe patient-reported breast/chest wall pain declined from 63% ( n = 15) at baseline to 18% ( n = 3) at 6 months. Physical, emotional, and social functioning improved over time and was comparable to scores of the Dutch reference population. Conclusion: The results of this pilot study suggest that a compression vest could be an acceptable and effective treatment option for patients with painful breast/chest wall edema. In compliant patients, swelling and pain was significantly reduced.
- Published
- 2020
- Full Text
- View/download PDF